Similarly, the pro-inflammatory markers TNFα and IL6 expression were also notably decreased in the AAV-miR-129-5p-treated CRS group compared to the CRS group (Figs 4G and 4H). The gene discussed is IL6; the disease is congenital rubella syndrome.